Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10555-025-10273-3.

Title:
Prospects and limitations of NK cell adoptive therapy in clinical applications | Cancer and Metastasis Reviews
Description:
During the last three decades, there has been substantial advancement in comprehending the chemical attributes and roles of natural killer (NK) cells, resulting in a growing interest in these cells. Simultaneously, the swift advancement of adoptive transfer therapy for immune cells, particularly the impressive achievements of autologous chimeric antigen receptor-T (CAR-T) cells in treating hematological malignant tumors, has fueled interest in using immune cells as a cancer treatment modality and opened the door for NK cell adoptive immunotherapy. NK cell-mediated immunotherapy has shown potential as a readily available, safe, and effective treatment for patients with leukemia. Moreover, clinical studies have demonstrated that NK cell adoptive immunotherapy shows efficacy in various solid tumors and hematologic malignancies, indicating a promising future for this therapeutic approach. This paper will provide an overview of NK cell adoptive therapy, focusing on current clinical trial results and the challenges associated with clinical applications.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {๐Ÿ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {๐Ÿ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of link.springer.com audience?

๐ŸŒ  Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {๐Ÿ’ธ}

We're unsure how the site profits.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {๐Ÿ”}

pubmed, article, google, scholar, cells, cas, cell, killer, natural, cancer, central, blood, immunology, journal, therapy, nature, clinical, immunotherapy, human, httpsdoiorgblood, httpsdoiorgs, science, stem, tumor, function, patients, leukemia, adoptive, chen, medicine, research, reviews, zhang, chimeric, antigen, receptor, cord, phase, immune, acute, innate, oncology, activity, supplement, tumors, study, lymphoma, allogeneic, wang, advanced,

Topics {โœ’๏ธ}

pd-1/pd-l1 axis modulates anti-pd-l1 antibody efficacy death receptor-mediated cytotoxicity monoclonal anti-pd-1 antibody month download article/chapter chimeric antigen receptor chimeric antigen receptor cd19-positive lymphoid tumors cell-derived interleukin-22 drives nk cell-mediated immunotherapy human anti-ctla-4 antibodies relapsed/refractory b-cell lymphoma single-cell transcriptomics reveal single-cell rna sequencing vivo anti-myeloma effect multi-antigen targeted derived natural killer metastatic her2-positive gastric anti-pd-1 therapy higher-risk myelodysplastic syndrome bacterial/viral immune responses cd39/cd73/a2ar pathway receptorsโ€”redefining innate immunity natural killer cells anti-myeloma activity cell stem cell adoptive cell therapy /iia open label allogeneic transplantation promotes syk-independent regulatory pathway haploidentical hematopoietic transplantation umbilical cord blood full article pdf mitochondrial stress induced human cell line human nk cells adoptive nk cells tumor-derived pge2 allogeneic nk cells chimeric receptor allogeneic car nk activating nk receptor nk cell subset nk cell activity immune-suppressor cells lentiviral based transfection induces specific killing car-nk cells stem cell reviews versus peripheral blood

Questions {โ“}

  • Innate or adaptive immunity?

Schema {๐Ÿ—บ๏ธ}

WebPage:
      mainEntity:
         headline:Prospects and limitations of NK cell adoptive therapy in clinical applications
         description:During the last three decades, there has been substantial advancement in comprehending the chemical attributes and roles of natural killer (NK) cells, resulting in a growing interest in these cells. Simultaneously, the swift advancement of adoptive transfer therapy for immune cells, particularly the impressive achievements of autologous chimeric antigen receptor-T (CAR-T) cells in treating hematological malignant tumors, has fueled interest in using immune cells as a cancer treatment modality and opened the door for NK cell adoptive immunotherapy. NK cell-mediated immunotherapy has shown potential as a readily available, safe, and effective treatment for patients with leukemia. Moreover, clinical studies have demonstrated that NK cell adoptive immunotherapy shows efficacy in various solid tumors and hematologic malignancies, indicating a promising future for this therapeutic approach. This paper will provide an overview of NK cell adoptive therapy, focusing on current clinical trial results and the challenges associated with clinical applications.
         datePublished:2025-06-25T00:00:00Z
         dateModified:2025-06-25T00:00:00Z
         pageStart:1
         pageEnd:21
         sameAs:https://doi.org/10.1007/s10555-025-10273-3
         keywords:
            NK cells
            Genetic manipulation
            Adoptive therapy
            Clinical trails
            Cancer Research
            Oncology
            Biomedicine
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-025-10273-3/MediaObjects/10555_2025_10273_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-025-10273-3/MediaObjects/10555_2025_10273_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-025-10273-3/MediaObjects/10555_2025_10273_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-025-10273-3/MediaObjects/10555_2025_10273_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-025-10273-3/MediaObjects/10555_2025_10273_Fig5_HTML.png
         isPartOf:
            name:Cancer and Metastasis Reviews
            issn:
               1573-7233
            volumeNumber:44
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yamin Deng
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chen Wu
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jintong Na
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jing Tang
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Simin Qin
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhiyong Zhang
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
                     name:Robert-Wood-Johnson Medical School University Hospital, Rutgers University
                     address:
                        name:Department of Surgery, Robert-Wood-Johnson Medical School University Hospital, Rutgers University, New Brunswick, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Liping Zhong
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
                     name:Guangxi Medical University
                     address:
                        name:Pharmaceutical College, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Prospects and limitations of NK cell adoptive therapy in clinical applications
      description:During the last three decades, there has been substantial advancement in comprehending the chemical attributes and roles of natural killer (NK) cells, resulting in a growing interest in these cells. Simultaneously, the swift advancement of adoptive transfer therapy for immune cells, particularly the impressive achievements of autologous chimeric antigen receptor-T (CAR-T) cells in treating hematological malignant tumors, has fueled interest in using immune cells as a cancer treatment modality and opened the door for NK cell adoptive immunotherapy. NK cell-mediated immunotherapy has shown potential as a readily available, safe, and effective treatment for patients with leukemia. Moreover, clinical studies have demonstrated that NK cell adoptive immunotherapy shows efficacy in various solid tumors and hematologic malignancies, indicating a promising future for this therapeutic approach. This paper will provide an overview of NK cell adoptive therapy, focusing on current clinical trial results and the challenges associated with clinical applications.
      datePublished:2025-06-25T00:00:00Z
      dateModified:2025-06-25T00:00:00Z
      pageStart:1
      pageEnd:21
      sameAs:https://doi.org/10.1007/s10555-025-10273-3
      keywords:
         NK cells
         Genetic manipulation
         Adoptive therapy
         Clinical trails
         Cancer Research
         Oncology
         Biomedicine
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-025-10273-3/MediaObjects/10555_2025_10273_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-025-10273-3/MediaObjects/10555_2025_10273_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-025-10273-3/MediaObjects/10555_2025_10273_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-025-10273-3/MediaObjects/10555_2025_10273_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10555-025-10273-3/MediaObjects/10555_2025_10273_Fig5_HTML.png
      isPartOf:
         name:Cancer and Metastasis Reviews
         issn:
            1573-7233
         volumeNumber:44
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yamin Deng
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chen Wu
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jintong Na
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jing Tang
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Simin Qin
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhiyong Zhang
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
                  name:Robert-Wood-Johnson Medical School University Hospital, Rutgers University
                  address:
                     name:Department of Surgery, Robert-Wood-Johnson Medical School University Hospital, Rutgers University, New Brunswick, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Liping Zhong
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
                  name:Guangxi Medical University
                  address:
                     name:Pharmaceutical College, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer and Metastasis Reviews
      issn:
         1573-7233
      volumeNumber:44
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Guangxi Medical University
      address:
         name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Robert-Wood-Johnson Medical School University Hospital, Rutgers University
      address:
         name:Department of Surgery, Robert-Wood-Johnson Medical School University Hospital, Rutgers University, New Brunswick, USA
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:Pharmaceutical College, Guangxi Medical University, Nanning, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yamin Deng
      affiliation:
            name:Guangxi Medical University
            address:
               name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Chen Wu
      affiliation:
            name:Guangxi Medical University
            address:
               name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Jintong Na
      affiliation:
            name:Guangxi Medical University
            address:
               name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Jing Tang
      affiliation:
            name:Guangxi Medical University
            address:
               name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Simin Qin
      affiliation:
            name:Guangxi Medical University
            address:
               name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Zhiyong Zhang
      affiliation:
            name:Guangxi Medical University
            address:
               name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
            name:Robert-Wood-Johnson Medical School University Hospital, Rutgers University
            address:
               name:Department of Surgery, Robert-Wood-Johnson Medical School University Hospital, Rutgers University, New Brunswick, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Liping Zhong
      affiliation:
            name:Guangxi Medical University
            address:
               name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
            name:Guangxi Medical University
            address:
               name:Pharmaceutical College, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
      name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
      name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
      name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
      name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
      name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
      name:Department of Surgery, Robert-Wood-Johnson Medical School University Hospital, Rutgers University, New Brunswick, USA
      name:State Key Laboratory of Targeting Oncology, National Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Major New Drugs Innovation and Development, Guangxi Medical University, Nanning, China
      name:Pharmaceutical College, Guangxi Medical University, Nanning, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {๐Ÿ”—}(612)

Analytics and Tracking {๐Ÿ“Š}

  • Google Tag Manager

Libraries {๐Ÿ“š}

  • Clipboard.js
  • Prism.js

CDN Services {๐Ÿ“ฆ}

  • Crossref

4.92s.